Today, I review, link to, and excerpt from StatPearls‘ “Coronary CT Angiography”. Pirbhat Shams; Omar Kousa; Amgad N. Makaryus. Last Update: January 23, 2026.
All that follows is from the above resource.
Continuing Education Activity
Coronary computed tomography angiography (CCTA) is a noninvasive imaging modality that uses multidetector computed tomography with intravenous contrast to visualize the coronary arteries, cardiac anatomy, and surrounding structures with high spatial resolution. This modality enables accurate assessment of coronary artery stenosis, plaque morphology (calcified, noncalcified, or mixed), and congenital or anomalous coronary anatomy. CCTA plays a central role in evaluating patients with stable chest pain, equivocal stress testing, or low-to-intermediate pretest probability of coronary artery disease, offering an excellent negative predictive value and facilitating early diagnosis, risk stratification, and preventive management.
Through participation in this course, clinicians strengthen their ability to appropriately select patients for CCTA, interpret key imaging findings, and integrate results into evidence-based clinical decision-making. Learners gain practical knowledge of technical considerations, image acquisition, radiation dose optimization, and common pitfalls, as well as an understanding of how CCTA compares with functional testing and invasive angiography. The course also emphasizes interdisciplinary collaboration among cardiologists, radiologists, technologists, and referring clinicians to optimize diagnostic accuracy, patient safety, and downstream care planning.
Objectives:
Identify appropriate candidates for coronary computed tomography angiography based on clinical indications and pretest coronary artery disease probability. Differentiate between the indications and contraindications for coronary computed tomography angiography compared to other coronary artery disease evaluation modalities, such as stress testing or invasive coronary angiography. Assess coronary computed tomography angiography images effectively to identify and evaluate coronary artery stenosis, plaque characteristics, and other relevant findings. Collaborate with radiologists and cardiologists in interpreting coronary computed tomography angiography results and developing appropriate treatment plans.Access free multiple choice questions on this topic.
Introduction
Chest pain is the most common symptom of coronary artery disease (CAD), posing a significant diagnostic challenge for clinicians. Despite remarkable strides in medical and procedural treatments, cardiovascular disease persists as a major global health concern. Addressing this burden demands timely and cost-effective diagnostic tools. Coronary computed tomography angiography (CCTA) is a crucial diagnostic modality for CAD assessment. This noninvasive approach is invaluable for patients with low-to-intermediate pretest probabilities of ischemic heart disease, underscoring its role in evaluating stable patients who do not require immediate revascularization.[1][2][3]
While invasive coronary angiography remains the diagnostic gold standard, CCTA is increasingly recognized as a noninvasive, low-risk alternative. This modality circumvents the hazards associated with invasive procedures and expedites assessments for patients at intermediate risk of CAD. Given the minute dimensions and dynamic nature of epicardial coronary arteries, CCTA requires precise spatial and temporal resolution. Spatial resolution determines the smallest distinguishable distance between 2 points, while temporal resolution dictates how rapidly images of moving structures can be captured. With the advent of 64-slice multi-detector CT systems and contemporary technologies, CCTA now boasts the necessary spatial and temporal resolution to visualize even the most distal coronary artery segments (see Image. Coronary Computed Tomography Angiography).
Anatomy and Physiology
The CCTA is a radiographic procedure that enables clinicians to closely evaluate the heart and its components, including the atria, ventricles, pericardium, great cardiac vessels, myocardium, and intracardiac valves. This diagnostic test involves a radiographic assessment of the epicardial coronary arteries, facilitated using a contrast agent. Although standard cardiac CT windows may provide limited visualization of adjacent pulmonary and osseous structures, CCTA provides valuable information. A thorough understanding of coronary anatomy is imperative for accurate interpretation of CT coronary angiograms.
Google Search: Normal Coronary Anatomy
Normal Coronary Anatomy
The left main artery arises from the posterior left aortic cusp. This artery typically measures 1 to 2 cm in length and bifurcates into the left anterior descending artery (LAD) and the left circumflex artery (LCx). In 0.41% of patients, the left main artery is absent, and both the LAD and LCx arise individually from the left aortic cusp. The LAD exits to the left of the pulmonary artery and travels down anteriorly in the anterior interventricular groove. Major branches from the LAD include septal perforators, which supply the anterior two-thirds of the interventricular septum, and diagonal branches, which supply the lateral wall of the left ventricle (LV).
The LCx turns back into the left atrioventricular groove and gives branches called the obtuse marginal, which supply the lateral aspect of the LV. The LCx, through its course, is covered by the left auricle. In one-third of cases, the left main artery trifurcates into the LAD, LCx, and ramus intermedius, which runs between the course of LAD and LCx, supplying the anterolateral wall of the LV. The right coronary artery (RCA) originates from the anterior aspect of the right aortic cusp. The RCA runs forward into the right atrioventricular (AV) groove until the crux (a point of intersection of the right AV groove and posterior interventricular groove) divides into the posterolateral branch and the posterior descending artery (PDA). In a left-dominant system, the PDA arises from the LCx.
Indications
Studies assessing the diagnostic performance of CCTA have typically compared its ability to detect significant coronary lesions (stenoses greater than 50%) with lesions identified in the same patients on subsequent invasive coronary angiography. Initial studies of 64-slice multidetector CT reported diagnostic sensitivity of 94%, specificity of 97%, positive predictive value of 87%, and negative predictive value of 99%.[4] These initial studies typically excluded patients with atrial fibrillation, atrial premature contractions, ventricular premature contractions, prior history of CAD, and an inability to tolerate beta-blockade. The reported accuracy of CCTA in chronic atrial fibrillation is 95.2% for sensitivity and 97.6% for specificity.[5]
CCTA protocols typically include an initial noncontrast, low-radiation-dose phase. This noncontrast portion of the study can yield high-quality data on cardiac anatomical structures that may not be adequately visualized with other noninvasive imaging modalities, eg, transthoracic echocardiography or cardiac magnetic resonance imaging. Contrast images can be instrumental in diagnosing and managing adult congenital heart disease (CHD). Simple CHD includes an atrial septal defect, patent foramen ovale, ventricular septal defect, and bicuspid aortic valve.
Complex CHD can also be assessed with reasonable accuracy, including Ebstein anomaly, truncus arteriosus, hypoplastic left heart syndrome, transposition of great arteries, Tetralogy of Fallot, and tricuspid atresia. Specifically, with cases of complex CHD, many of these patients benefit from surgical repair and can survive to adulthood. CCTA provides an accurate, timely, and cost-effective means of initial diagnosis and follow-up care in these patients.
Calcium scoring (CAC score) is a valuable parameter derived from the noncontrast portion of a CCTA and is also known as the Agatston score. This score is used to stratify patients into low-, intermediate-, and high-risk groups for future CAD development. While CAC scores are useful in identifying asymptomatic individuals who require more intensive preventative treatment, they are rarely appropriate for symptomatic patients. Guidelines suggest that CCTA may be a more appropriate diagnostic tool for symptomatic patients with an intermediate pretest probability of coronary disease. CAC scores are determined by assigning a weighted density score to the location of calcium with the highest attenuation, measured in Hounsfield units during the initial noncontrast phase of a CCTA, and then multiplying it by the area of calcification.
CAC scores are classified into 4 risk assessment categories based on their values:
Very low risk: 0 Mildly increased risk: 1–99 Moderately increased risk: 100–299 Moderate-to-severely increased risk: ≥ 300 [6]Patients with CAC scores of 0 or 1 to 10 have a very low lifetime risk of adverse cardiovascular events. However, results from studies have shown that patients with mild CAC scores of 1 to 10 are at 3 times the risk of developing CAD compared with those with a CAC score of 0. These findings have led to additional investigations into the roles of noncalcified coronary artery plaque, rapid atherosclerosis, and plaque destabilization in the development of coronary heart disease. Assessing these additional plaque features using CAC scoring alone can be challenging, particularly for noncalcified coronary artery plaques, which can range from nonobstructive to significantly stenotic.
CCTA can also be used to diagnose coronary anomalies. As with CAD, invasive coronary angiography has been the diagnostic gold standard. However, owing to the temporal and spatial resolution of modern CT scanners, CCTA has emerged as a viable and robust noninvasive alternative for assessing coronary anatomy. Coronary anomalies are present in less than 1% of the population, and presentations can range from benign, incidental findings to dramatic, as in the case of sudden cardiac death. Anomalous coronary arteries are classified into 3 general groups: anomalies of origin and course, intrinsic coronary anatomy anomalies, and anomalies of arterial termination.
In addition to assessing coronary anatomy, CCTA enables 3-dimensional imaging of the entire heart and the spatial arrangement of anomalous coronary arteries, which can, in turn, provide prognostic information. Newer CCTA applications in perfusion and fractional flow reserve areas are on the horizon and are set to expand the diagnostic utility of cardiac CT. Additionally, transcatheter structural invasive procedures are now routinely performed and are guided by noninvasive cardiac imaging, specifically CCTA preprocedurally.[7][8][9][10] According to the Society of Cardiovascular Computed Tomography 2021 Expert Consensus Document on Coronary Computed Tomographic Angiography, the following are the appropriate indications for CCTA in patients with CAD.[11]
CCTA in native vessels for evaluation of stable coronary artery disease:
CCTA is appropriate as a first-line investigation in patients with no known CAD, with typical stable, atypical, or angina-equivalent symptoms. CCTA is appropriate as a first-line investigation in patients with known CAD, with typical stable, atypical, or angina equivalent symptoms. CCTA is appropriate for evaluating CAD following inconclusive functional testing. CCTA may be appropriate for the assessment of asymptomatic individuals who are at high risk of having CAD. CCTA is rarely appropriate in asymptomatic low-to-intermediate risk patients or symptomatic very low-risk individuals.CCTA for evaluation of stable coronary artery disease post-revascularization:
CCTA is appropriate in symptomatic patients with coronary stent diameters greater than 3 mm. CCTA may be appropriate for symptomatic patients with coronary stent diameters of less than 3 mm, particularly those with thin struts of less than 100 micrometers in proximal, nonbifurcating vessels. CCTA is appropriate for evaluating graft patency in patients with prior coronary artery bypass grafting. CCTA is appropriate for assessing grafts and other structures before redoing cardiac surgery.CCTA for evaluation of stable coronary artery disease using fractional flow reserve or CT perfusion:
CCTA may be appropriate for the functional assessment of intermediate stenosis (30%-90%) in multivessel disease to guide decisions regarding invasive coronary angiography and revascularization. Adding fractional flow reserve or stress CT enhances the overall diagnostic value of CCTA.CCTA for evaluation of stable CAD in miscellaneous conditions:
Valvular heart disease and low risk for CAD Nonischemic cardiomyopathy and low risk for CAD Coronary artery anomalies Screening of coronary allograft vasculopathy Scar assessment in patients who cannot undergo cardiac MRI Electrocardiogram gating of patients undergoing CCTA for aortic dissection and pulmonary embolism to assess CAD in men older than 45 and women older than 55Contraindications
There are generally no absolute contraindications to performing a CCTA. However, a history of a severe anaphylactic reaction to iodinated contrast precludes a repeat contrast administration. The following are the relative contraindications:
Acute thyroid storm Pregnancy Renal insufficiency (defined as creatinine clearance less than 30 mL/min/1.73 m2) Inability to hold breath for more than 5 seconds Patients on radioactive iodine therapy Hemodynamic instability Acute decompensated heart failure Patient’s height and weight above the recommended scanner thresholdsEquipment
The Society for Cardiovascular Computed Tomography recommends that, at a minimum, a 64-slice CT scanner be used for CCTA.[11] Dual-head power-injection pumps should be used to enable biphasic and triphasic injection protocols. Digital images should be stored in the Digital Imaging and Communications in Medicine format. A picture archiving and communication system should be available to enable review of the entire image set acquired during the scan.
- 11. Narula J, Chandrashekhar Y, Ahmadi A, Abbara S, Berman DS, Blankstein R, Leipsic J, Newby D, Nicol ED, Nieman K, Shaw L, Villines TC, Williams M, Hecht HS. SCCT 2021 Expert Consensus Document on Coronary Computed Tomographic Angiography: A Report of the Society of Cardiovascular Computed Tomography. J Cardiovasc Comput Tomogr. 2021 May-Jun;15(3):192-217. [PMC free article] [PubMed]
Personnel
The Society for Cardiovascular Computed Tomography recommends that CCTAs be performed by technologists adequately trained to use contrast injection devices and to perform cardiac CTs and CCTAs. One team member should be proficient in inserting peripheral intravenous catheters. During image acquisition, a team member certified in advanced cardiac life support should also be available. Finally, a clinician trained in administering beta-blockers and nitroglycerin should also be present during the scan. The interpreting clinician should be trained in CCTA in accordance with the respective clinical competence statements of the American College of Cardiology and the American Heart Association.
Preparation
Key facts to consider for the preparation of CCTA include the following:



